Nicotine as a typical drug of abuse in experimental animals and humans

被引:91
|
作者
Le Foll, B [1 ]
Goldberg, SR [1 ]
机构
[1] NIDA, Preclin Pharmacol Sect, Behav Neurosci Res Branch, NIH,Dept Hlth & Human Serv, Baltimore, MD 21224 USA
关键词
D O I
10.1007/s00213-005-0155-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale and background: Tobacco use through cigarette smoking is the leading preventable cause of death in the developed world. Nicotine, a psychoactive component of tobacco, appears to play a major role in tobacco dependence, but reinforcing effects of nicotine often are difficult to demonstrate directly in controlled laboratory studies with animal or human subjects. Objective: To review the major findings obtained with various procedures developed to study dependence-related behavioral effects of nicotine in experimental animals and humans, i.e., drug self-administration, conditioned place preference, subjective reports of nicotine effects and nicotine discrimination, withdrawal signs, and ratings of drug withdrawal. Results: Nicotine can function as an effective reinforcer of drug-seeking and drug-taking behavior both in experimental animals and humans under appropriate conditions. Interruption of chronic nicotine exposure produces withdrawal symptoms that may contribute to relapse. Difficulties encountered in demonstrating reinforcing effects of nicotine under some conditions, relative to other drugs of abuse, may be due to weaker primary reinforcing effects of nicotine or to a more critical contribution of environmental stimuli to the maintenance of drug-seeking and drug-taking behavior with nicotine than with other drugs of abuse. Further experiments are also needed to delineate the role other chemical substances inhaled along with nicotine in tobacco smoke play in sustaining smoking behavior. Conclusions: Nicotine acts as a typical drug of abuse in experimental animals and humans.
引用
收藏
页码:367 / 381
页数:15
相关论文
共 50 条
  • [41] DEGENERATIVE ALTERATIONS OF RENAL VASCULATURE IN HUMANS AND EXPERIMENTAL ANIMALS
    SZANTO, PB
    NELSON, D
    IVY, AC
    POPPER, H
    JOURNALS OF GERONTOLOGY, 1951, 6 (04): : 154 - 155
  • [42] Shifting pharmacology of nicotine use and withdrawal: Breaking the cycle of drug abuse
    Sesia, Thibaut
    Grace, Anthony A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (08) : 2697 - 2698
  • [43] Modeling risk factors for nicotine and other drug abuse in the preclinical laboratory
    Carroll, Marilyn E.
    Anker, Justin J.
    Perry, Jennifer L.
    DRUG AND ALCOHOL DEPENDENCE, 2009, 104 : S70 - S78
  • [44] Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse
    Van Skike, C. E.
    Maggio, S. E.
    Reynolds, A. R.
    Casey, E. M.
    Bardo, M. T.
    Dwoskin, L. P.
    Prendergast, M. A.
    Nixon, K.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2016, 65 : 269 - 287
  • [45] Typical humans
    Krauss, Lawrence
    NEW SCIENTIST, 2008, 198 (2656) : 23 - 23
  • [46] Pioglitazone, a PPARy agonist, reduces nicotine craving in humans, with marginal effects on abuse potential
    Jones, Jermaine D.
    Comer, Sandra D.
    Metz, Verena E.
    Manubay, Jeanne M.
    Mogali, Shanthi
    Ciccocioppo, Roberto
    Martinez, Suky
    Murntaz, Mudassir
    Bisaga, Adam
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2017, 163 : 90 - 100
  • [47] TRANSFERABILITY OF DRUG-ACTION DATA FROM ANIMALS TO HUMANS
    LOSCHER, W
    MARQUARDT, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1993, 118 (34-35) : 1254 - 1263
  • [48] Drug resistance in the genus Enterococcus - current problem in humans and animals
    Talaga-Cwiertnia, Katarzyna
    Bulanda, Malgorzata
    POSTEPY MIKROBIOLOGII, 2018, 57 (03): : 244 - 250
  • [49] Metabolism and excretion of the antiepileptic/antimigraine drug, topiramate in animals and humans
    G. W. Caldwell
    W. N. Wu
    J. A. Masucci
    L. A. Mckown
    D. Gauthier
    W. J. Jones
    G. C. Leo
    B. E. Maryanoff
    European Journal of Drug Metabolism and Pharmacokinetics, 2005, 30 : 151 - 164
  • [50] The orbital prefrontal cortex and drug addiction in laboratory animals and humans
    Everitt, Barry J.
    Hutcheson, Daniel M.
    Ersche, Karen D.
    Pelloux, Yann
    Dalley, Jeffrey W.
    Robbins, Trevor W.
    LINKING AFFECT TO ACTION: CRITICAL CONTRIBUTIONS OF THE ORBITOFRONTAL CORTEX, 2007, 1121 : 576 - 597